NDC00006-3298-22: DACTINOMYCIN FOR INJECTION.
The DACTINOMYCIN FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, special_features: 500 MICROGRAMS OF DACTINOMYCIN; WITH 20 MG MANNITOL, primary_container_type: VIAL, SINGLE DOSE, supplementary_features: NOTE: D; ANTINEOPLASTIC (CHEMOTHERAPY) DRUG, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-902-1222, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| special_features | 500 MICROGRAMS OF DACTINOMYCIN; WITH 20 MG MANNITOL |
| primary_container_type | VIAL, SINGLE DOSE |
| supplementary_features | NOTE: D; ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 0.500 MILLIGRAMS OF ACTIVE INGREDIENT |
| active_medicament_medicinal_strength | 0.500 MILLIGRAMS DACTINOMYCIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | DACTINOMYCIN FOR INJECTION USP 0.5MG VIAL |
| NSN | 6505-00-902-1222 |
| PRIMARY CONTAINER CONTENT QUANTITY | 0.500 MILLIGRAMS OF ACTIVE INGREDIENT |
| SUPPLEMENTARY FEATURES | NOTE: D; ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| SPECIAL FEATURES | 500 MICROGRAMS OF DACTINOMYCIN; WITH 20 MG MANNITOL |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DACTINOMYCIN FOR INJECTION USP 0.5MG VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS DACTINOMYCIN ACTIVE INGREDIENT |